The leading life sciences reagents and instruments company is expected to announce its fiscal second-quarter earnings for ...

Bio-Techne (TECH) is back in focus after a recent analyst downgrade that cited softer organic growth and a weaker free cash ...

Discover how earnings announcements impact market dynamics, why they matter to investors, and how analysts anticipate market reactions. Stay informed with key insights.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

(RTTNews) - Several healthcare and biotech stocks posted notable gains in Monday's after-hours trading following earnings updates and guidance revisions. KalVista Pharmaceuticals Inc. (KALV) rose ...

Good morning, and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year 2026. [Operator Instructions] I would now like to turn the call over to David Clair, ...

Bio-Techne Corporation TECH reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of 42 cents, which matched the Zacks Consensus Estimate. The bottom line remained flat on a ...

MINNEAPOLIS, Nov. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (TECH) today reported its financial results for the first quarter ended September 30, 2025. First Quarter FY2026 Highlights First ...

Use of Non-GAAP Financial Measures: This press release contains financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (GAAP). We ...